Mechanism of Action and Clinical Indications of Urea Cream
Urea cream works as a keratolytic agent by dissolving the intracellular matrix of the stratum corneum, which loosens and promotes shedding of hyperkeratotic skin, while simultaneously acting as a humectant to hydrate the epidermis. 1
Mechanism of Action
Urea functions through multiple complementary pathways:
Keratolytic effect: Urea dissolves the intracellular matrix between keratinocytes, resulting in loosening of the horny layer and regular shedding of scaly skin, thereby softening hyperkeratotic areas 1
Hygroscopic properties: As a component of the natural moisturizing factor (NMF), urea absorbs and retains water in the epidermis, essential for adequate hydration and stratum corneum integrity 2
Barrier enhancement: Urea regulates gene expression in keratinocytes relevant for differentiation and antimicrobial peptide production, improving overall skin barrier function including antimicrobial defense 2
Penetration enhancement: Urea increases skin penetration of other topical medications, optimizing their therapeutic action 3
Clinical Indications
According to FDA labeling, urea is indicated for 1:
- Hyperkeratotic conditions: dry/rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses
- Wound care: debridement and promotion of normal healing where healing is retarded by local infection, necrotic tissue, or eschar
- Nail disorders: damaged, ingrown, and devitalized nails
Concentration-Dependent Effects
The therapeutic effect varies by concentration 4:
- ≥10% concentration: Required for keratolytic action and reduction of scaling/skin thickening
- Up to 40% concentration: Used for localized severe thickening (e.g., joints, palmoplantar keratoderma)
- <10% concentration: Functions primarily as a moisturizer 3
Application Guidelines
- Frequency: Apply once or twice daily, tapering as clinical response allows 4
- Avoid sensitive areas: May cause irritation on face or flexures 4
Critical Safety Considerations
Urea should NOT be used in the neonatal period (first 6-12 months) except on very limited areas such as palms and soles 4. This restriction exists because:
- Epidermal barrier defects in congenital ichthyoses increase systemic absorption risk
- Immature stratum corneum in infants
- Higher body-surface-to-mass ratio increases toxicity risk
- High blood urea concentrations have been documented after cutaneous application of 10% urea in collodion babies and infants with lamellar ichthyosis 4
Evidence Quality
The 2025 British Journal of Dermatology guidelines 4 represent the highest quality evidence available, based on systematic literature review including double-blind randomized controlled trials (DBRCTs) demonstrating that keratolytics like urea are more effective than emollients alone for reducing scaling and skin thickening. While no specific keratolytic has proven superior to others, urea remains the most commonly used agent in clinical practice.